ATE389670T1 - Selektive peptidische agonisten des vpac2- rezeptors - Google Patents

Selektive peptidische agonisten des vpac2- rezeptors

Info

Publication number
ATE389670T1
ATE389670T1 AT05749168T AT05749168T ATE389670T1 AT E389670 T1 ATE389670 T1 AT E389670T1 AT 05749168 T AT05749168 T AT 05749168T AT 05749168 T AT05749168 T AT 05749168T AT E389670 T1 ATE389670 T1 AT E389670T1
Authority
AT
Austria
Prior art keywords
vpac2 receptor
peptidic agonists
selective peptidic
selective
agonists
Prior art date
Application number
AT05749168T
Other languages
English (en)
Inventor
Bengt Krister Bokvist
Robert Cummins
Wolfgang Glaesner
Jesper Lindgren Gromada
John Mayer
Lianshan Zhang
Jorge Alsina-Fernandez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE389670T1 publication Critical patent/ATE389670T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT05749168T 2004-05-21 2005-05-19 Selektive peptidische agonisten des vpac2- rezeptors ATE389670T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57308004P 2004-05-21 2004-05-21

Publications (1)

Publication Number Publication Date
ATE389670T1 true ATE389670T1 (de) 2008-04-15

Family

ID=34993247

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05749168T ATE389670T1 (de) 2004-05-21 2005-05-19 Selektive peptidische agonisten des vpac2- rezeptors

Country Status (7)

Country Link
US (1) US20080096811A1 (de)
EP (1) EP1753780B1 (de)
AT (1) ATE389670T1 (de)
CA (1) CA2567635A1 (de)
DE (1) DE602005005476T2 (de)
ES (1) ES2302201T3 (de)
WO (1) WO2005113593A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070067136A (ko) 2004-10-08 2007-06-27 포베스 메디-테크 (리서치) 인코포레이티드 혈관작용성 장내 폴리펩티드 제약
US7595294B2 (en) * 2004-10-08 2009-09-29 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide pharmaceuticals
US20090170775A1 (en) * 2004-10-08 2009-07-02 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide compositions
EP1896048A4 (de) * 2005-05-06 2010-11-03 Bayer Pharmaceuticals Corp Pacap (pituitary adenylate cyclase activating peptide)-rezeptor (vpac2)-agonisten und ihre pharmakologischen anwendungsverfahren
KR101057284B1 (ko) * 2005-10-26 2011-08-16 일라이 릴리 앤드 캄파니 선택적 ｖｐａｃ２ 수용체 펩티드 작동제
AU2006322656B2 (en) * 2005-12-09 2012-03-08 Vectus Biosystems Limited VIP fragments and methods of use
JP2009528376A (ja) * 2006-02-28 2009-08-06 イーライ リリー アンド カンパニー 選択的ｖｐａｃ２受容体ペプチドアゴニスト
IN2012DN02120A (de) * 2009-08-14 2015-08-21 Phasebio Pharmaceuticals Inc
ES2669190T3 (es) 2011-06-06 2018-05-24 Phasebio Pharmaceuticals, Inc. Uso de péptidos intestinales vasoactivos modificados en el tratamiento de la hipertensión
EP3139949B1 (de) * 2014-05-08 2020-07-29 Phasebio Pharmaceuticals, Inc. Zusammensetzungen enthaltend ein vip-elp fusionsprotein zur verwendung in der behandlung von mukoviszidose
ES2822598T3 (es) 2015-02-09 2021-05-04 Phasebio Pharmaceuticals Inc Métodos y composiciones para tratar enfermedades y trastornos musculares
CN109134610B (zh) * 2017-06-27 2022-07-08 尚华医药科技(江西)有限公司 一种肽类化合物、其应用及含其的组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04193896A (ja) * 1989-10-26 1992-07-13 Meiji Seika Kaisha Ltd 活性ペプチド
JPH0692991A (ja) * 1991-02-28 1994-04-05 Daicel Chem Ind Ltd 新規活性ペプチド
US6242563B1 (en) * 1998-07-20 2001-06-05 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Peptide analogues
DE60039111D1 (de) * 1999-09-28 2008-07-17 Bayer Corp Agonisten des rezeptors 3 (r3) von pituitary adenylate cyclase aktivierendem peptid (pacap) und ihre pharmakologische verwendung
US7378494B2 (en) * 2002-07-12 2008-05-27 Bayer Healthcare Ag Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonist peptide

Also Published As

Publication number Publication date
DE602005005476T2 (de) 2009-03-05
DE602005005476D1 (de) 2008-04-30
EP1753780B1 (de) 2008-03-19
ES2302201T3 (es) 2008-07-01
EP1753780A1 (de) 2007-02-21
US20080096811A1 (en) 2008-04-24
CA2567635A1 (en) 2005-12-01
WO2005113593A1 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
NO20082345L (no) Selektive VPAC2 reseptorpeptidagonister
ATE529442T1 (de) Verbesserte humane interferon-moleküle und ihre verwendungen
WO2006097536A3 (en) Dimeric peptide agonists of the glp-1 receptor
GB2436266A (en) Modified human growth hormone
GB0700909D0 (en) Novel antigen-binding polypeptides and their uses
EA200600055A1 (ru) Агонисты рецептора меланокортина 4 (мк4 ) и их применение
EA200701918A1 (ru) Белок липокалин
MXPA06011924A (es) Dispositivo de liberacion continua base polimeros.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
EP1791553A4 (de) Zusammensetzungen zur abgabe von peptid yy und pyy agonisten
WO2007101146A3 (en) Selective vpac2 receptor peptide agonists
WO2007133828A3 (en) Selective vpac2 receptor peptide agonists
MXPA06003474A (es) Agonistas de receptores de melanocortina.
CY1110980T1 (el) Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες
ATE546463T1 (de) Modifizierte humane wachstumshormon-polypeptide und ihre verwendungen
EA200701448A1 (ru) Специфически связывающаяся с крипто-антигеном человека молекула (варианты), композиция на ее основе (варианты), способ получения молекулы, способ лечения посредством молекулы (варианты) и способ ингибирования крипто-экспрессии в клетке больного
DE602005005476D1 (de) Selektive peptidische agonisten des vpac2-rezeptors
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
WO2006023356A3 (en) Selective vpac2 receptor peptide agonists
SG10201803541TA (en) Biologically active c-terminal arginine-containing peptides
ATE412010T1 (de) Selektive peptidische agonisten des vpac2- rezeptors
EA200702193A1 (ru) Гликозилирование белков
MX2007005526A (es) Tratamiento de mastitis con enrofloxacino.
AU309683S (en) Massaging belt
DE602005013650D1 (de) Proteinhydrolysat zur behandlung von müdigkeit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties